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Abstract
Introduction: Accelerometry of the upper extremity (UE) potentially provides infor-
mation on the extent of activities in daily life in patients with Duchenne muscular
dystrophy (DMD). The objective of this study is to evaluate the validity of home mea-
surements of UE accelerometry.
Methods: This was a cross-sectional study in 16 patients with DMD (aged 7-17 years).
Patients were monitored for 1 to 3 days with two accelerometers on the UE and one
accelerometer on the wheelchair.
Results: The mean intensity of activity and the mean frequency of transfers of arm
elevation from low to middle were approximately twofold higher in patients with a
Brooke scale score of 1 or 2 than in patients with a Brooke scale score of 3 or 4. Cor-
relations with the Performance of Upper Limb scale score were high for intensity and
for the total frequency of arm elevations per hour.
Discussion: Intensity, percentage of time in middle orientation, and frequency of
transfers of the upper arm correlated well with functional measurements.
K E YWORD S
accelerometer, ambulant, DMD, Duchenne muscular dystrophy, monitoring, physical activity,
upper extremity
1 | INTRODUCTION
In children/adolescents with Duchenne muscular dystrophy (DMD),
progressive weakness results in loss of ambulation at a mean age of
13 years when treated with corticosteroids.1 From about 11 years
onward, the Brooke scale score (grading the upper extremity
[UE] activity level in boys/adolescents with DMD) starts to increase,
indicating a decline in UE function. Because of this, in combination
with increased life expectancy, males with DMD now live longer with
functional limitations of the UE and 70% experience UE limitations
when performing social activities.2-4
To evaluate the effect of treatments on daily activity, an objective
measure with standardized information is required.5-8 Although func-
tional outcomes provide information about the level of functional
capacity and activity function,9 it is unclear how these can be general-
ized to actual daily life performance. Evaluating UE function in home
settings will give better insights. Currently, diaries are widely used;
Abbreviations: DMD, Duchenne muscular dystrophy; LA, lower arm; PUL, Performance of
Upper Limb; UA, upper arm; UE, upper extremity.
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however, they are time consuming for patients, subjective, and, there-
fore, probably less reliable.10,11 Accelerometers could provide a more
objective measure.12
Accelerometers have been shown to be useful in monitoring gait
(eg, overall physical activity level, step activity and gait alterations) in
boys with DMD and in children with other neurological diseases.13-21
Most of the experience with the use of accelerometers in the UEs is
in adult patients with stroke and multiple sclerosis.22-25 Uswatte
et al26 showed that if complementary self-reported measures are used
simultaneously they can provide rich information about UE activities.
In children with DMD, a movement monitor for UE movements was
tested during specific tasks in a controlled setting27 but not in a home
situation.
In previous studies with accelerometers to measure UE function,
various parameters were used. Intensity (or movement counts) of
movement was recommended as a parameter in several stud-
ies.23,24,28,29 Koene et al12 questioned the relationship between mea-
sured intensity and UE function in children with mitochondrial disease
because a high level of nonpurposeful activity influences the registra-
tion of the parameter intensity. However, this specifically applies to
children with movement disorders such as ataxia. Other mentioned
parameters are the duration of arm use in combination with a jerk
index, level of arm elevation, mean of rotation rate, and elevation
rate.12,25,27 The objective of this pilot study was to evaluate the valid-
ity of three acceleration-based parameters on UE activity in at-home
situations as an outcome measure in ambulant and wheelchair depen-
dent boys/adolescents with DMD.
2 | MATERIALS AND METHODS
2.1 | Study design and participants
Eligible participants were boys/adolescent boys ranging in age from
7 to 17 years with a DNA-established diagnosis of DMD who were
ambulant or wheelchair dependent with a Brooke scale score of 1-4
(this will be discussed more fully below in Clinical outcome measures).
Patients were voluntarily recruited as part of the “Gainboy study” ran-
domized controlled trial.30 For this pilot study, only preintervention
measures were used. The study was approved by the medical ethical
committee Arnhem-Nijmegen, the Netherlands (NL41708.091.12)/
2012/390); all parents provided written informed consent, and ado-
lescent boys 12 years and older provided assent. All data were han-
dled according to the guidelines of Good Clinical Practice (GCP).
2.2 | Instruments
2.2.1 | Sensors
The participants were instructed to wear three accelerometers (MOX
Accelerometry; Maastricht Instruments BV, Maastricht, the Nether-
lands) for at least 1 day but preferably 3 consecutive days. The
accelerometers measure accelerations in three directions with a sam-
ple frequency of 25 HZ and are capable of measuring activity during a
period of at least 7 days. One accelerometer was fixed on the upper
arm (UA), one on the lower arm (LA), and one on the wheelchair or
the trousers to discriminate movements of the arm from movements
of the rest of the body. Patients were instructed to take the acceler-
ometers off during sleeping, showering, and swimming. To estimate
the amount of daily activity, three parameters were calculated from
the acceleration data of each sensor according to a set of standard-
ized procedures.28 We chose to use intensity, level of arm elevation
(orientation), and elevation rate (frequency of arm elevation) as
parameters because these were expected to fit with the functional
abilities of boys/adolescents with DMD.23,24,27-29
The first parameter was activity counts (intensity), which was cal-
culated by integrating the acceleration during 1-minute episodes and
TABLE 1 Patient characteristics
Variables
Participants,
n Mean ± SD (range)
Age, y 16 12.4 ± 3.2 (7-17)
Brooke scale score 16
1 3
2 8
3 4
4 1
Vignos scale score 16
2 2
3 2
4 1
8 2
9 9
Total PUL scale score 16 55.7 ± 15.8 (27-74)
Duration, min 15 1601.0 ± 506.2 (390-2239)
Intensity LA, bouts/min 15 306.3 ± 138.1 (120-571)
Intensity UA, bouts/
min
15 231.5 ± 95.2 (92-387)
Intensity wheelchair/
trunk, bouts/min
15 70.3 ± 50.7 (36-191)
Orientation-low, % of
time
15 72.1 ± 19.3 (22-97)
Orientation-middle, %
of time
15 24.1 ± 15.6 (3-61)
Orientation-high, % of
time
15 3.8 ± 4.8 (0-17)
Frequency of UA
transfer low-middle,
per h
15 28.9 ± 15.4 (4.9-52.8)
Frequency of UA
transfers
middle-high, per h
15 4.7 ± 7.2 (0.2-27.6)
Abbreviations: LA, lower arm; PUL scale, Performance of Upper Limb
scale; UA, upper arm.
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summing this outcome over all three axes. A constant acceleration of
1 g (gravitational constant) during 1 minute corresponds with 1000
counts.28 The second parameter was level of elevation during a period
of 1 second, also referred to as orientation. Data were categorized as
low (<45), middle (45-90), or high (>90) elevation of the arm
according to the UA sensor.29 The third parameter was transfer of arm
elevation, which was the frequency of elevation of the arm from low
to middle elevation and from middle to high elevation.
2.2.2 | Clinical outcome measures
Patients completed a physical activity diary (a diagram on paper) for
2 to 3 consecutive days. Every half hour they recorded which activity
was performed. Because it was difficult to quantitate the data
recorded the diary, we visually compared the information from the
diary and the data from accelerometers for two random participants.
In addition, we compared our results with two existing and validated
scales for upper extremity functioning, the Brooke scale and the Per-
formance of Upper Limb (PUL) scale because there is no definite gold
standard for measuring activity in daily life. The Brooke scale was
used to classify UE functioning with scores from 1 to 6 (higher scores
indicate worse functionality).31 The PUL scale is a validated functional
test that assesses UE function at the shoulder, mid-elbow, and hand.32
The total sum score ranges from 0 to 74, with higher scores indicating
better function. We also compared our results with a validated scale
for ambulation, the Vignos scale (range 1-10; higher scores indicate
worse functionality). The Brooke, Vignos, and PUL scales were all per-
formed on the same day, prior to wearing the sensors.
2.3 | Statistical analyses
Data were analyzed in MATLAB 7.12 (The MathWorks, Natick,
Massachusetts). Statistical analyses were performed in SPSS 24 for
Windows (IBM, Armonk, New York). Spearman correlation coefficient
F IGURE 1 Two examples of measurements of upper arm (UA), lower arm (LA) and wheelchair activity compared with the information
recorded in the diaries of two participants. Y-axis is intensity (counts/min). In the first participant (top graph), higher activity levels for LA and UA
can be observed during sports and during playing with a home video game with a handheld remote controller. In addition, the sensor on the
wheelchair shows activity when driving in the car or during sports. The results of the second participant show most activity of the UA and LA
during therapy and less activity during watching television. Wheelchair activity can be clearly distinguished during driving in a car and when using
the wheelchair, for example for going to the toilet at school, although, at about 19:45, the starting time of driving car and measured activity of the
wheelchair is not exactly the same
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was used to assess the correlation between intensity, orientation, and
frequency of transfers and the PUL scale result and with age. Correla-
tion coefficients were interpreted as 0 to 0.25, little to none; 0.26 to
0.49, low; 0.50 to 0.69, moderate; 0.70 to 0.89, high; and ≥ 0.90, very
high.33 Mean differences in accelerometer parameters (intensity, ori-
entation, and frequency of transfers of arm elevation) between partic-
ipants with a Brooke score of 1 or 2 and those with a Brooke score of
3 or 4 were calculated by using independent t tests. In all tests,
P < .05 was considered statistically significant.
3 | RESULTS
Sixteen boys/adolescent boys with DMD were included, with a mean
age of 12.4 ± 3.2 years (range, 7-17). Eleven participants had a Brooke
score of 1 or 2, and five had a Brooke score of 3 or 4 (Table 1). Partici-
pants wore the accelerometers for a mean of 29 hours spread over a
maximum period of 3 days (range, 6.5-37 hours). In one participant
(age 13 years, Brooke score 2, total PUL scale score 73), the acceler-
ometers did not work. In two other participants, the accelerometer
stopped measuring after 1 day; in these two patients, we used the
data from day 1 only.
There seemed to be a clear relationship between the activities
recorded in the diary by the participants and the activity measured by
the accelerometers (Figure 1). It becomes clear (Figure 1) that, in both
patients, the total level of wheelchair activity is relatively small com-
pared with the activity levels of the LA vs UA except for driving in a
car (participant 2). Even during sports (participant 2), arm activity
levels can be clearly distinguished from the higher than normal wheel-
chair activity level.
3.1 | Intensity
Figure 2A shows that the intensity (activity count/min) of the UE
is lower in patients with higher Brooke scales. Because of the
F IGURE 2 A,Mean intensity (activity count/min) in different Brooke scale scores. B,Mean intensity (activity count/min) in the combined Brooke
scale scores (Brooke scale scores 1 and 2; Brooke scale scores 3 and 4). Error bars (b) indicate 95% confidential interval. C,Mean intensity (activity count/
min) in relation to the age of the patients. D,Mean intensity (activity count/minute) in relation to the Performance ofUpper Limb (PUL) scale score
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small number of patients per Brooke scale score, participants
were grouped into two groups according to their Brooke scale
score (Figure 2B). The mean intensity of both LA and UA is about
twofold higher in patients with a Brooke scale score of 1 or
2 (LA mean 378 counts/min, SD 119; UA mean 279 counts/min,
SD 84) compared with a Brooke scale score of 3 or 4 (LA mean
166 counts/min, SD 35; UA mean 138 counts/min, SD 33;
P < .05). The intensity of UA and LA activity correlated moder-
ately with age, UA (R = −0.54), and LA (R = −0.55; both P < .05;
Figure 2C). A very high correlation was seen between the
intensity of UA and LA (R = 0.95, P < .01). There was a high cor-
relation between intensity and PUL scale score (LA: R = 0.82,
P < .01; UA: R = 0.84, P < .01; Figure 2D).
Because of the small number of patients per Vignos scale score,
participants were grouped into two groups according to their Vignos
scale score. The mean intensity of both LA and UA is about 1.5-fold
higher in patients with a Vignos scale score of 2 to 4 (LA mean
405 counts/min, SD 125; UA mean 297 counts/min SD 84) compared
with a Vignos scale score of 8 or 9 (LA mean 257 counts/min, SD
120; UA mean 198 counts/min, SD 85; P = .05).
F IGURE 3 A, Percentage of time in a specific orientation with the upper arm (low, <45; middle, 45-90; and high >90) for different Brooke
scale scores. B, Percentage of time in a specific orientation with the upper arm (low, <45; middle, 45-90; and high >90) in relation to the
Performance of Upper Limb (PUL) scale score
F IGURE 4 A, Mean amount of transfers of arm elevation per hour in patients with different Brooke scale scores. B, Transfers of upper arm
elevation per hour in relation to the Performance of Upper Limb (PUL) scale score
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3.2 | Orientation of UA
For the whole group, the mean time spent in low orientation was the
highest (67.6%); less time (22.6%) was spent in middle orientation,
and the least time was spent in high orientation. For participants with
a Brooke scale score of 1, the mean percentage of time spent in low
orientation was 43.6%, mean percentage of time spent in middle ori-
entation 47.2%, and mean percentage of time spent in high orienta-
tion 9.3% (Figure 3A).
For the combined Brooke scale groups, mean percentage of time
in low orientation was 65.4% in those with a Brooke scale score of
1 or 2 and 85.5% in those with a Brooke scale score of 3 or
4 (P = .05). The mean percentage of time in middle orientation was
29.9% in the group with a Brooke scale score of 1 or 2 and 12.5% in
the group with Brooke scale score of 3 or 4 (P < .05). The mean per-
centage of time in high orientation was 4.7% in the group with a
Brooke scale score of 1 or 2 and 2.0% in the group with a Brooke
score of 3 or 4 (P = .3).
3.3 | Transfers of arm elevation
No relevant difference was seen in the mean amount of transfers of
UA elevation per hour between low to middle (mean 28.9) and middle
to low (mean 28.92) or between middle to high (4.69) and high to mid-
dle (mean 4.82) orientation. Therefore, only the transfers from low to
middle and middle to high orientation are shown (Figure 4A). The
mean amount of transfers from low to middle orientation in partici-
pants with a Brooke scale score of 1 or 2 was 35.9 per hour (SD 13.4);
in participants with a Brooke scale score 3 or 4, it was 14.9 per hour
(SD 7.4; P < .01). The mean amount of transfers from middle to high
orientation in participants with a Brooke scale score of 1 or 2 was
6.7/hour (SD 8.2); in those with a Brooke scale score of 3 or 4, it was
0.7/hour (SD 0.6; P = .14). There was a moderate correlation between
number of transfers per hour and PUL scale score from low-middle
(R = 0.59, P < .05) and from middle-high (R = 0.69, P < .01), and there
was a high correlation between the total number of transfers per hour
and the PUL scale score (R = 0.76, P < .01; Figure 4B).
4 | DISCUSSION
Le Moing et al27 showed that variables of a wireless movement moni-
tor correlated well with the scores obtained by using other previously
validated tests in the UE, but this was in a controlled setting and not
in the at-home situation. We showed that in boys/adolescents with
DMD, the results of the at–home-measured parameters are related to
our current standards for measuring function of the upper extremity
(Brooke and PUL scale scores).31,32 Although these two latter func-
tional outcomes provide information about the level of functional
capacity and activity, it is unclear how these can be generalized to
actual daily life performance. Evaluating UE function in the home set-
ting with sensors will give better insights into daily functioning at
home. Our finding that accelerometry can be used as an objective out-
come measurement correlates with findings in studies of patients with
different diagnoses and with findings from studies for lower extremity
function in DMD.12,16,23,26
There appears to be a clear relationship between the activities
recorded in the diaries by the participants and the activity measured
by the accelerometers. The comparison between the two (Figure 1)
shows that the use of an accelerometer is sensitive to differences
between activities; however, demonstrating this was not the objective
of our study. In the second participant in Figure 1 (bottom graph),
some information from the diary was missing, and a difference was
seen in the starting time of driving according to the diary and the
measurements of the accelerometers. It is reasonable to assume that
starting times in the diary are not very precise.
Only a small portion of the total intensity of movements was
attributable to movements of the wheelchair or trunk, probably
because most of the time the children sat (even those without a
wheelchair) or stayed in one place with their wheelchair. The simulta-
neous use of two different sensors (UA and LA) appears to convey no
meaningful advantage compared with a single sensor for the measure-
ment of intensity because there was a very high correlation between
the two. Therefore, future studies could consider the use of only one
sensor instead of two on the UE (placed close to the wrist) and one
sensor on the wheelchair, especially because some participants
described wearing the sensors as bothersome. The accelerometers
were chosen for their light weight, small size, and ability to collect
data for long periods as well as the accessibility of raw data. New por-
table electronic devices with many types of sensors, such as
smartwatches, may be used in future studies. Although the percent-
age of time spent in high orientation was lowest in participants with
Brooke scale scores of 3 and 4, some movements were classified in
this category. This was unexpected because these participants were
unable to move the arms independently above shoulder level. They
could have used compensatory lateral flexion of the trunk, thus lifting
their arms, or, alternatively, their arm movements may have been
supported by caregivers or mechanical arm supports. This cannot be
determined with the methods used in this study.
Limitations of this study include the relatively small sample, espe-
cially the low number of participants with Brooke scale scores of 3 or
4. This also could explain why some scores in the Brooke 4 group
were higher than those in the Brooke 3 group. However, the preva-
lence of this disease in the community is very low, and this is an
exploratory pilot study. We believe that the results are sufficiently
encouraging to consider this approach in a broader population.
Another limitation is that we measured a relatively short time period
because of a concern of the burden to the boys/adolescents of filling
out diaries and wearing sensors for longer periods. We also did not
correct for the period during which the sensors were worn (season,
weekdays, or weekend), although a recent study showed an effect of
season on the activity pattern of children with neuromuscular dis-
eases.34 A third limitation is that we did not select participants with
specific mutations because as our research questions where more
general, assessing the feasibility and validity of the method. A final
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limitation is that no data were available for one patient, and that
data for two other patients were available for only 1 day because
the accelerometers stopped functioning. Future studies should con-
sider using sensors with in-the-moment real time data, such as an
application with an option to correct technical problems with the
sensors.
In conclusion, our study provides new insights into the measure-
ment of daily activity in boys/adolescents with DMD in at-home situ-
ations. In boys/adolescents with DMD, both the intensity of activity
and the frequency of transfers of the upper extremity are related to
our current standards for measuring functioning of the arms (Brooke
and PUL scales). The intensity of activity of the upper extremity as
measured with accelerometers in daily life is related to the current
standard for measuring activity in the at-home situation by the use of
diaries. Accelerometry seems to be a valid method to measure activity
at home.
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